NICE recommends SIRT Therapy for neuroendocrine tumours
We are delighted to share with you the news that NICE has recommended SIRT (selective internal radiation therapy) for the treatment of neuroendocrine tumour- related liver metastases. NICE Interventional procedures guidance [IPG786]: Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver: Published 16th May 2024
What is SIRT and what does this mean for our community?
SIRT is a radiotherapy treatment that targets tumours within the liver, that cannot be safely removed through surgery. It is sometimes also called radio-embolisation or Trans Arterial Radio-Embolisation (TARE). It can be used for primary liver cancers or for cancer that has spread to the liver from another site. For example: liver metastases from a primary bowel neuroendocrine tumour. The aim of SIRT is to stop or significantly slow the growth of cancer. The additional benefit that may be seen in neuroendocrine tumours, is that it may also reduce some of the hormone-associated symptoms that are caused by the tumours. e.g., Carcinoid Syndrome. SIRT may be performed alone or in combination with other therapies.
Read more on page 10
Beth has remained part of the Neuroendocrine Cancer UK team in a freelance capacity over the past few years whilst studying. However, we are thrilled to announce that she is now joining the team in a permanent capacity, part time, to carry out the role of Digital Support Coordinator. She will be responsible for various design activities across the charity, including this quarterly newsletter! Welcome back, Beth! Welcome (back), Beth!
4
www.neuroendocrinecancer.org.uk
Made with FlippingBook interactive PDF creator